- AU$30.65m
- AU$24.15m
- AU$4.05m
Australia Stock Exchange release from EMYRIA : Emyria adds wearables to psychedelic-assisted therapy trials
Australia Stock Exchange release from EMYRIA : PRE_NR Ends: 09:31:11
Brief: Emyria Seeks Trading Halt
Australia Stock Exchange release from EMYRIA : Trading Halt
Australia Stock Exchange release from EMYRIA : Pause in Trading
Australia's Emyria climbs on positive animal study data for CBD capsules
Australia Stock Exchange release from EMYRIA : PRE_NR Ends: 10:01:30
Australia Stock Exchange release from EMYRIA : Positive animal data for Emyrias ultra-pure CBD capsule
Australia Stock Exchange release from EMYRIA : Positive initial MDMA-analogue screening results
Australia Stock Exchange release from EMYRIA : PRE_NR Ends: 09:55:46
Australia Stock Exchange release from EMYRIA : Change of Director's Interest Notice KS
Australia Stock Exchange release from EMYRIA : Application for quotation of securities - EMD
Australia Stock Exchange release from EMYRIA : Notice under section 708A(5)(e) of the Corporations Act
Australia Stock Exchange release from EMYRIA : Application for quotation of securities - EMD
Australia Stock Exchange release from EMYRIA : Application for quotation of securities - EMD
Australia Stock Exchange release from EMYRIA : Initial Director's Interest Notice KS
Brief: Emyria Says Karen Smith To Join Emyria's Board As An Executive Director
Australia Stock Exchange release from EMYRIA : Emyria Appoints Global Pharma Expert Dr Karen Smith to Board
Australia Stock Exchange release from EMYRIA : Emyria Anoints Global Pharma Expert Dr Karen Smith to Board